J&J (DIA3006)

A Randomized, Double-Blind, Placebo and  Active-Controlled, 4-Arm, Parallel- Group, Multicenter Study Evaluate the Efficacy, Safety,  and Tolerability of JNJ- 28431754  (Canagliflozin) Compared with Sitagliptin  and Placebo in the Treatment of Subjects With Type 2 Diabetes Mellitus With  Inadequate Glycemic Control on Metformin Monotherapy


Trials Status

Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials.
Latin Clinical Trial Center
1801 Ponce de Leon Ave,
Suite 205, San Juan, PR 00909
787-249-4763 (24/7)
Fax: 787-982-7100
© 2023 Latin Clinical Trial Center. All Rights Reserved.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram